Heartbeam (BEAT) Stock Price

Heartbeam Price

NASDAQ·CLOSED
0.54
​
Market closed

Revenue has compounded at 21.8% per year over the past 13 years to 439.11 M USD. Earnings per share have grown at 11.5% per year over the last 10 years. Heartbeam's net margin stands at -0.2%, down from 4.2% several years earlier.

Heartbeam stock price

Access this data via the Eulerpool API

Heartbeam business model & stock analysis

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 15 full-time employees. The company went IPO on 2021-10-14. The firm is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The firm is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional (3D) vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection.

Frequently asked questions about Heartbeam

9 analysts currently rate the Heartbeam stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Heartbeam to generate revenue of 275,000.00 USD and earnings per share of -0.38 USD.

Converted at the current exchange rate, the Heartbeam share trades at 0.48 EUR (0.54 USD).

The Heartbeam share (BEAT) is listed on 1 stock exchanges, including: NASDAQ (BEAT).

The expected revenue of Heartbeam is 275,000.00 USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Heartbeam is -12.92 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Heartbeam is currently -1.42. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Heartbeam stock.

The price-to-sales ratio (P/S) of Heartbeam is currently 66.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Heartbeam stock.

The Eulerpool Quality Score for Heartbeam is 1/10.

The ISIN of Heartbeam is US42238H1086. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Heartbeam is BEAT. The ticker symbol is used to trade Heartbeam shares on the stock exchange.

Fair ValueTerminal
0.46 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 14, 2021
ISIN
US42238H1086
Cusip
42238H108
Market capitalization
18.30 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-1.42
P/Ee 2027
-1.89
P/Ee 2028
-2.36
P/Ee 2029
2.17
P/Ee 2030
0.90
P/S
P/Se
66.56
EV/EBIT
—
P/B Ratio
7.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-807.34 %
Last updated Oct 8, 2026, 4:20 AM

Heartbeam Peer Group

Heartbeam Ticker

NASDAQ · BEAT

Heartbeam FIGI

BEAT:US · BBG012F6HZX2BEAT:UA · BBG012F6J3Z9BEAT:UC · BBG012F6J405BEAT:UN · BBG012F6J423BEAT:UP · BBG012F6J432BEAT:UB · BBG012F6J450BEAT:UM · BBG012F6J478BEAT:UX · BBG012F6J487BEAT:UR · BBG012F6J496BEAT:UD · BBG012F6J4F9BEAT:UF · BBG012F6J4J5BEAT:VY · BBG012F6J4K3

All fundamentals and in-depth analysis of Heartbeam

Our stock analysis for Heartbeam stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Heartbeam. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.